PDC*line Pharma Revenue and Competitors
Estimated Revenue & Valuation
- PDC*line Pharma's estimated annual revenue is currently $7.6M per year.
- PDC*line Pharma's estimated revenue per employee is $155,000
- PDC*line Pharma's total funding is $72M.
Employee Data
- PDC*line Pharma has 49 Employees.
- PDC*line Pharma grew their employee count by 7% last year.
PDC*line Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Co-Founder & President | Reveal Email/Phone |
3 | HR & administrative officer | Reveal Email/Phone |
4 | Medical Director | Reveal Email/Phone |
5 | R&D Manager | Reveal Email/Phone |
6 | Clinical Trial Manager | Reveal Email/Phone |
7 | QC & Process Development Manager | Reveal Email/Phone |
8 | Accounting & Administrative assistant | Reveal Email/Phone |
9 | Ingénieur recherche | Reveal Email/Phone |
10 | Ingénieure de Recherche | Reveal Email/Phone |
PDC*line Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 63 | 133% | $22.9M | N/A |
#2 | $15.7M | 101 | 25% | N/A | N/A |
#3 | $35.5M | 229 | 21% | N/A | N/A |
#4 | $26.7M | 172 | 153% | N/A | N/A |
#5 | $13.6M | 88 | 69% | N/A | N/A |
#6 | $17.2M | 111 | 25% | N/A | N/A |
#7 | $7.6M | 49 | 7% | $71.8M | N/A |
#8 | $7.8M | 50 | 138% | $16.5M | N/A |
#9 | $5.1M | 33 | 0% | $24.6M | N/A |
#10 | $1.1M | 7 | N/A | N/A | N/A |
What Is PDC*line Pharma?
PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid Dendritic Cells (PDC*line). Based on a robust preclinical package and a first-in-human phase Ib in melanoma, PDC*line Pharma reported promising Phase I/II results in lung cancer (PDC*lung) in 2024. Preparations are now underway for a randomized Phase II trial in lung cancer, and a Phase Ib trial in colorectal cancer with neoantigens (PDC*neo). The company has raised €61M in equity and non-dilutive funding and signed a €108M licensing deal in Asia with the Korean pharmaceutical company, LG Chem Life Science.
keywords:N/A
$72M
Total Funding
49
Number of Employees
$7.6M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Liège
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.9M | 55 | 31% | N/A |
#2 | $9.4M | 58 | -8% | N/A |
#3 | $14.3M | 59 | 74% | N/A |
#4 | $11.2M | 62 | 17% | N/A |
#5 | $10M | 62 | 51% | N/A |